| Oct 29 |
Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders
|
| Oct 29 |
Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat
|
| Oct 29 |
Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript
|
| Oct 29 |
Harmony Biosciences Holdings, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Oct 29 |
Harmony Biosciences Holdings, Inc. (HRMY) Q3 2024 Earnings Call Transcript
|
| Oct 29 |
Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates
|
| Oct 29 |
Harmony Biosciences GAAP EPS of $0.79, revenue of $186M
|
| Oct 29 |
HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS
|
| Oct 28 |
Harmony Biosciences Q3 2024 Earnings Preview
|
| Oct 23 |
Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
|
